Description:

SOUTHWEST ONCOLOGY GROUP Post-Consolidation Treatment Summary Form: Gemtuzumab Ozogamicin (S0521) Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1024CCDD-8EF2-4085-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1024CCDD-8EF2-4085-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/8/15
Uploaded on:

January 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Leukemia NCT00492856 Treatment - SOUTHWEST ONCOLOGY GROUP Post-Consolidation Treatment Summary Form: Gemtuzumab Ozogamicin (S0521) - 2466403v1.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP Post-Consolidation Treatment Summary Form: Gemtuzumab Ozogamicin (S0521)
    1. No Instruction available.
Header
Participating Group Name
Patient And Disease Description
Vital Status
Physical
Kg
Gemtuzumab Ozogamicin
Was first dose of Gemtuzumab Ozogamicin given
Was second dose of Gemtuzumab Ozogamicin given
Was third dose of Gemtuzumab Ozogamicin given
Was fourth dose of Gemtuzumab Ozogamicin given
Was fifth dose of Gemtuzumab Ozogamicin given
Was sixth dose of Gemtuzumab Ozogamicin given
Treatment: Growth Factors
If yes,
Was growth factor permanently discontined during this reporting period?
Was growth factor permanently discontined during this reporting period?
Treatment: Other Therapy
Did the patient receive other therapy during this reporting period? (If yes, give start and end dates and describe the other therapy in the Comments section.)
Dose Modifications
Were there any dose modifications or additions/omissions to protocol treatment?
Comments

Similar models